主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HRTX
#3001
Heron Therapeutics, Inc.
1.1
9
-0.83%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.83%
每月变动
-14.39%
6个月变化
-11.85%
年变化
-39.90%
前一天收盘价
1.2
0
Open
1.1
9
Bid
Ask
Low
1.1
9
High
1.1
9
交易量
58
市场
股票
医疗保健
HRTX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
91.4 M
102.14 M
119.26 M
150.33 M
152.33 M
188.54 M
—
Valuation ratios
Enterprise value
1.83 B
842 M
274.44 M
255.44 M
207.26 M
217.5 M
1.03 B
Price to earnings ratio
—
—
-1.46
-2.36
-17
-10.83
-165
Price to sales ratio
—
—
2.46
2.05
1.62
—
—
Price to cash flow ratio
—
—
1.8
4.44
10.35
7.85
43.64
Price to book ratio
—
—
19.49
7.68
6.93
16.32
23.56
Enterprise value to EBITDA ratio
279.79
239.48
15.14
16.78
3.78
—
—
Profitability ratios
Return on assets %
0.64
0.72
0.73
0.5
0.06
0.08
0.08
Return on equity %
0.96
2.84
13.41
3.25
0.4
1.41
1.21
Return on invested capital %
1 091.33
872.93
674.56
465.61
48.29
8.33
—
Gross margin %
59.15
46.7
49.04
48.75
73.21
73.31
293.19
Operating margin %
257.52
252.27
162.21
87.07
7.99
1.64
7.58
EBITDA margin %
7.38
4.07
16.83
11.98
37.96
46.87
148.46
Net margin %
256.52
255.58
169.03
87.02
9.41
13.04
52.44
Liquidity ratios
Quick ratio
2.66
2.9
1.83
1.84
1.7
1.51
5.58
Current ratio
3.07
3.58
2.49
2.37
2.29
2.48
8.25
Inventory turnover
1.08
1.02
1.07
1.35
0.81
0.57
0.61
Asset turnover
0.2
0.26
0.39
0.54
0.63
0.63
0.64
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.49
0.59
0.67
0.64
0.13
1.54
Long term debt to total equity ratio
—
1.92
11
4.4
4.45
2.28
15.2
Per share metrics
Operating cash flow per share
—
—
1.35
0.43
0.15
0.17
0.16
EBIT per share
—
—
0.14
0.09
0.34
0.42
0.31
EBITDA per share
—
—
0.17
0.11
0.36
0.44
0.33
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
0.78
0.58
0.39
0.28
1.13
Net current asset value per share
—
—
1.89
1.37
1.37
1.43
5.23
Tangible book value per share
—
—
0.12
0.25
0.22
0.08
0.44
Working capital per share
—
—
1.13
0.79
0.77
0.85
1.99
Book value per share
—
—
0.12
0.25
0.22
0.08
0.44
新闻
Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript
Heron Therapeutics Q4 每股收益 逊于预期, 营收 超出预期
Heron Therapeuti earnings missed, revenue topped estimates
Heron 2025年第四季度业绩:急症护理需求激增推动ZYNRELEF增长48%
Heron Q4 2025 slides: acute care surge drives 48% ZYNRELEF growth
海伦治疗公司股价因强劲的第四季度收入增长而飙升
Heron Therapeutics stock soars after strong Q4 revenue growth
海伦治疗公司的APONVIE在新术后恶心指南中获得推荐
Heron’s APONVIE featured in new postoperative nausea guidelines
Jefferies下调Heron Therapeutics股票目标价,因肿瘤业务下滑
Jefferies lowers Heron Therapeutics stock price target on oncology franchise decline
Heron Therapeutics, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:HRTX) 2025-11-04